Chemotherapy

FILE - In this May 5, 2019, file photo Alex Trebek poses in the press room at the 46th annual Daytime Emmy Awards at the Pasadena Civic Center in Pasadena, Calif. Trebek said Tuesday, Sept. 17, that he’s had a setback in his battle with pancreatic cancer and is undergoing chemotherapy again.(Photo by Richard Shotwell/Invision/AP, File)
September 17, 2019 - 3:42 pm
NEW YORK (AP) — "Jeopardy!" host Alex Trebek says he's had a setback in his battle with pancreatic cancer and is undergoing chemotherapy again. Trebek told ABC's "Good Morning America" on Tuesday that after a short period of optimism when he stopped chemotherapy, his "numbers shot up" and doctors...
Read More
Cancer patient Kim Lauerman poses for a portrait in her home Wednesday, June 26, 2019, in Alpharetta, Ga. After Lauerman was diagnosed with ovarian cancer, doctors wanted to give her a drug that helps prevent infections and fever during chemotherapy. Her insurer said no. Doctors say they worry about the growing influence insurers have over patient care. They say treatment delays and the problems they create are becoming common because routine things like imaging exams or prescriptions now require insurer approval first. (AP Photo/John Bazemore)
July 29, 2019 - 2:01 pm
After Kim Lauerman was diagnosed with ovarian cancer, doctors wanted to give her a drug that helps prevent infections and fever during chemotherapy. Her insurer said no. Anthem Blue Cross told Lauerman the drug wasn't necessary. She eventually got it after an infection landed her in the hospital,...
Read More
June 03, 2019 - 5:12 pm
CHICAGO (AP) — Newer drugs are substantially improving the chances of survival for some people with hard-to-treat forms of lung, breast and prostate cancer, doctors reported at the world's largest cancer conference. Among those who have benefited is Roszell Mack Jr., who at age 87 is still able to...
Read More
FILE - This Oct. 14, 2015 file photo shows the Food & Drug Administration campus in Silver Spring, Md. On Friday, March 8, 2019, the FDA approved Roche’s Tecentriq, the first cancer immunotherapy for treating an aggressive type of breast cancer. (AP Photo/Andrew Harnik, File)
March 08, 2019 - 6:26 pm
The U.S. Food and Drug Administration has approved the first immunotherapy drug for breast cancer. Swiss drugmaker Roche's Tecentriq was OK'd Friday for treating advanced triple-negative breast cancer, which accounts for about 15 percent of cases. It's to be given with chemotherapy, the standard...
Read More
FILE - This undated fluorescence-colored microscope image made available by the National Institutes of Health in September 2016 shows a culture of human breast cancer cells. For the first time, one of the new immunotherapy drugs has shown promise against breast cancer in a large study that combined it with chemotherapy to treat an aggressive form of the disease. Results were discussed Saturday, Oct. 20, 2018 at a European Society for Medical Oncology conference in Munich and published by the New England Journal of Medicine. (Ewa Krawczyk/National Cancer Institute via AP)
October 20, 2018 - 12:01 pm
For the first time, one of the new immunotherapy drugs has shown promise against breast cancer in a large study that combined it with chemotherapy to treat an aggressive form of the disease. But the benefit for most women was small, raising questions about whether the treatment is worth its high...
Read More
The Rev. John Sabbagh, left, and his son Ebby Sabbagh hugs nurse practitioner Kim O'Riley, Friday, Sept. 7, 2018 in Gilbert, Ariz. Thirty-five years after a Mesa man cared for his son when he was shot in their native Lebanon, the son is returning that devotion. Both the Rev. John Ibraham Sabbagh and his 54-year-old son, Ebby Sabbagh, are celebrating one year of going strong since the elder Sabbagh received a crucial stem-cell transplant. (AP Photo/Terry Tang)
September 10, 2018 - 5:58 pm
GILBERT, Ariz. (AP) — Thirty-five years after an Arizona man cared for his son when he was shot in their native Lebanon, the son is returning that devotion. Both the Rev. John Ibraham Sabbagh and his 54-year-old son, Ebby Sabbagh, are celebrating one year of going strong since the elder Sabbagh...
Read More
New York Giants special teams coordinator Thomas McGaughey leaves after speaking to the media in East Rutherford, N.J., Thursday, Sept. 6, 2018. McGaughey has been doing more in the offseason than getting the Giants’ special teams ready for the opener against the Jacksonville Jaguars. The 45-year-old coordinator has undergoing treatment for a rare form of cancer that strikes roughly 8,000 people in the United States annually. (AP Photo/Tom Canavan, File)
September 06, 2018 - 2:50 pm
EAST RUTHERFORD, N.J. (AP) — Thomas McGaughey has been doing more in the offseason than getting the New York Giants' special teams ready for the opener against the Jacksonville Jaguars. The 45-year-old coordinator has been undergoing treatment for a rare form of cancer that strikes roughly 8,000...
Read More
FILE - In this Wednesday, Jan. 17, 2018 file photo, New York Mets' general manager Sandy Alderson speaks at a news conference at Citi Field in New York. Mets general manager Sandy Alderson is taking a leave of absence because his cancer has returned. The 70-year-old made the announcement before the game against Pittsburgh, Tuesday, June 26, 2018. (AP Photo/Seth Wenig, File)
June 27, 2018 - 1:41 am
NEW YORK (AP) — His voice quavering at an unexpected news conference, Sandy Alderson revealed what he had just told his team moments before. His cancer has returned, he's taking a leave of absence — and his up-and-down tenure as New York Mets general manager is essentially over. With the team in a...
Read More
FILE - In this Jan. 28, 2003, file photo, Rep. Stephanie Stuckey Benfield, D-Decatur, promotes the breast cancer prevention stamp from the well on the floor of the House in Atlanta. Countless breast cancer patients in the future will be spared millions of dollars of chemotherapy thanks in part to something that millions of Americans did that cost them just pennies: bought a postage stamp. Proceeds from the U.S. Postal Service's breast cancer stamp enabled a landmark study that showed which women need chemo and which do not. (AP Photo/Ric Feld, File)
June 04, 2018 - 4:58 pm
CHICAGO (AP) — Countless breast cancer patients in the future will be spared millions of dollars of chemotherapy thanks in part to something that millions of Americans did that cost them just pennies: bought a postage stamp. Proceeds from the U.S. Postal Service's breast cancer stamp put...
Read More
This undated microscope image from USC via the NIH shows pancreatic cancer cells, nuclei in blue, growing as a sphere encased in membranes, red. In a rare triumph for tough-to-beat pancreatic cancer, patients who had surgery lived substantially longer on a four-drug combo than on a standard cancer drug, according to research released on Monday, June 4, 2018. (Min Yu/Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC, USC Norris Comprehensive Cancer Center)
June 04, 2018 - 11:11 am
CHICAGO (AP) — Patients with pancreatic cancer that hadn't spread lived substantially longer on a four-drug combo than on a single standard cancer drug, a rare advance for a tough-to-treat disease, researchers reported Monday. The results indicate the powerful chemotherapy treatment known as...
Read More

Pages